人类多能干细胞的强有力的分化成施万细胞
Norie Tooi1, Rio Okama1, Haruka Sato1
1Stem Cell & Device Laboratory, Inc, OFFICE-ONE Shijo Karasuma 11F, 480, Niwatoriboko-cho, Shimogyo-ku, Kyoto, 600-8491, Japan.
Biochemical and biophysical research communications
|July 7, 2024
概括
研究人员开发了一种从干细胞中制造人类施万细胞 (SCs) 的方法,克服了研究SC疾病的局限性,并推进了这些疾病的药物发现和细胞治疗.
科学领域:
- 干细胞生物学 干细胞生物学
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
背景情况:
- 施万细胞 (SC) 相关疾病的研究受到人类SCs的稀缺性和低增殖的限制.
- 这种稀缺性阻碍了SC相关疾病的药物发现和细胞治疗的进展.
研究的目的:
- 开发一种强大的方法,将人类诱导多能干细胞 (hiPSC) 分化为功能性施万细胞 (SC).
- 为研究和治疗应用建立可靠的SCs来源.
主要方法:
- 建立了hiPSC线路并生成了大小控制的hiPSC聚合物.
- 使用专有酶溶液进行精确定时的治疗,以产生高纯度的施万细胞前体 (SCP).
- 扩展了SCPs并将它们分化为使用dibutyryl-cAMP (db-cAMP) 表达髓基本蛋白 (MBP) 的SCs.
主要成果:
- 从hiPSC聚合物中成功生成了高纯度的SCP.
- 实现了SCPs的高效扩张和分化为表达MBP的SCs.
- 证明了差异化的SCs在体外分泌了诱导神经元外生长的因素.
结论:
- 开发了一种高效和稳定的方法,可以从hiPSCs中生产SCs.
- 这种强大的诱导和成熟协议为药物发现和针对SC相关疾病的细胞治疗提供了宝贵的工具.
- 该方法有助于研究SCs和开发涉及SCs的神经疾病的治疗方法.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Induced Pluripotent Stem Cells
22.4K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.4K


